223 related articles for article (PubMed ID: 1353431)
21. Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID.
Aiuti A; Brigida I; Ferrua F; Cappelli B; Chiesa R; Marktel S; Roncarolo MG
Immunol Res; 2009; 44(1-3):150-9. PubMed ID: 19224139
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of ADA gene expression and transduction efficiency in ADA/SCID patients undergoing gene therapy.
Carlucci F; Tabucchi A; Aiuti A; Rosi F; Floccari F; Pagani R; Marinello E
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1245-8. PubMed ID: 15571238
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy for hematopoietic and immune disorders.
Kohn DB
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410
[TBL] [Abstract][Full Text] [Related]
24. Gene transfer to hematopoietic cells--the clinical experience.
Richter J
Eur J Haematol; 1997 Aug; 59(2):67-75. PubMed ID: 9293853
[No Abstract] [Full Text] [Related]
25. Gene therapy fulfilling its promise.
Kohn DB; Candotti F
N Engl J Med; 2009 Jan; 360(5):518-21. PubMed ID: 19179320
[No Abstract] [Full Text] [Related]
26. A new chance for SCID gene therapy.
Bordignon C
Nat Med; 1998 Jan; 4(1):19-20. PubMed ID: 9427599
[No Abstract] [Full Text] [Related]
27. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
Smogorzewska EM; Weinberg KI; Kohn DB
Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
[TBL] [Abstract][Full Text] [Related]
28. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
29. The third conference on hematopoietic stem cell gene therapy: biology and technology.
Emery DW; Bodine DM
Mol Ther; 2002 Jun; 5(6):658-63. PubMed ID: 12027548
[No Abstract] [Full Text] [Related]
30. Evolving Gene Therapy in Primary Immunodeficiency.
Thrasher AJ; Williams DA
Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy of primary T cell immunodeficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
[TBL] [Abstract][Full Text] [Related]
32. Gene transfer therapy for heritable disease: cell and expression targeting.
Mitani K; Clemens PR; Moseley AB; Caskey CT
Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):217-24. PubMed ID: 8097051
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy and bone marrow transplantation.
Kiem HP; von Kalle C; Schuening F; Storb R
Curr Opin Oncol; 1995 Mar; 7(2):107-14. PubMed ID: 7538791
[TBL] [Abstract][Full Text] [Related]
34. Opening Marrow Niches in Patients Undergoing Autologous Hematopoietic Stem Cell Gene Therapy.
Cowan MJ; Dvorak CC; Long-Boyle J
Hematol Oncol Clin North Am; 2017 Oct; 31(5):809-822. PubMed ID: 28895849
[TBL] [Abstract][Full Text] [Related]
35. Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.
Dunbar C; Chang L; Mullen C; Ramsey WJ; Carter C; Kohn D; Parkman R; Lenarsky C; Weinberg K; Wara D; Culver KW; Anderson WF; Leitman S; Fleisher T; Klein H; Shearer G; Clerici M; McGarrity G; Bastian J; Hershfield MS
Hum Gene Ther; 1999 Feb; 10(3):477-88. PubMed ID: 10048399
[No Abstract] [Full Text] [Related]
36. Progress towards hematopoietic stem cell gene therapy.
Kurre P; Kiem HP
Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
[TBL] [Abstract][Full Text] [Related]
37. Update on clinical gene therapy in childhood.
Qasim W; Gaspar HB; Thrasher AJ
Arch Dis Child; 2007 Nov; 92(11):1028-31. PubMed ID: 17954483
[TBL] [Abstract][Full Text] [Related]
38. Severe combined immunodeficiency disease, adenosine deaminase deficiency and gene therapy.
Parkman R; Gelfand EW
Curr Opin Immunol; 1991 Aug; 3(4):547-51. PubMed ID: 1755981
[TBL] [Abstract][Full Text] [Related]
39. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
[TBL] [Abstract][Full Text] [Related]
40. Fetal somatic gene therapy.
Douar AM; Themis M; Coutelle C
Mol Hum Reprod; 1996 Sep; 2(9):633-41. PubMed ID: 9239676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]